HealthMore in Health→
Biotech Funding and CAR-T Data Stay in Focus as Degron, CREATE, TenNor and Cabaletta Make News
Key Takeaways
- Degron Therapeutics raised an additional $40 million for its molecular glue degrader platform.
- The supplied excerpt says Degron has raised $95 million in total.
- The same Endpoints briefing also notes capital raises involving CREATE and TenNor and a CAR-T data update from Cabaletta.
DE
DT Editorial Team··via endpoints.news
